In a second article on the regulatory agenda in the European structured products market for 2017, the global derivatives and structured products team at Ashurst talks about disclosure and appropriateness, the role of compliance, potential issues around hedging disruption events, MREL and the difficulties of regulatory cross-border application. Regulators are now pushing back the responsibility around disclosure to manufacturers and distributors, according to Michael Logie, a partner at the firm

Continue reading and get unlimited access for 7 days with a free trial of SRP.

Get a free trial

Already a subscriber? Login